Global Registry
A4D-Ab
Acimtamig
A4DAB004
|
Phase-II
Target
FCGR3A/CD16/CD16A;TNFRSF8/CD30
Isotype / Subclass
non-canonical / None
Company
Affimed Therapeutics
Clinical Status
Phase-II
Format
Bispecific (VH-VK-VH'-VL Homodimer)
Synonyms
AFM13
AFM-13
pH Formulation
—
IMGT
PubChem (478838285)
PubChem (494431237)
PubChem (505057008)
Thera-SAbDab
YAbS
Avg A4D Score
-0.6236
Score Range
-0.64 to -0.6
Structures
2
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB004_7seg_H_L
7seg
97%
-0.6038
6.5
9.0
-0.1096
-0.6654
A4DAB004_7seg_A_B
7seg
97%
-0.6434
6.5
9.0
-0.0759
-0.7137